These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 24430032)
1. [The use of topiramate in the treatment of focal epilepsy in children]. Kremenchugskaia MR; Globa OV; Kuzenkova LM Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):33-8. PubMed ID: 24430032 [TBL] [Abstract][Full Text] [Related]
2. [Optimization of treatment focal forms of epilepsy in young children]. Sivkova SN; Milovanova OA; Zaĭkova FM Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):43-7. PubMed ID: 22027669 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
4. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
5. [Experience in combined topiramate therapy of drug-resistant epilepsy]. Karlov VA; Vlasov PN; Freĭdkova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):21-6. PubMed ID: 12938650 [TBL] [Abstract][Full Text] [Related]
6. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S; Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326 [TBL] [Abstract][Full Text] [Related]
7. [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children]. Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):39-44. PubMed ID: 20559266 [TBL] [Abstract][Full Text] [Related]
9. Topiramate: a new antiepileptic drug. Privitera MD Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443 [TBL] [Abstract][Full Text] [Related]
10. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures. Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB; Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance. Hogan RE; Blatt I; Lawson B; Nagaraddi V; Fakhoury TA; Anders B; Clark AM; Laine D; Halvorsen MB; Chung SS Epilepsy Behav; 2014 Dec; 41():136-9. PubMed ID: 25461205 [TBL] [Abstract][Full Text] [Related]
13. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group. Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of treatment of focal forms of epilepsy in children with antiepileptic drugs of different generations]. Sivkova SN; Mukhin KIu; Zaĭkova FM Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):42-8. PubMed ID: 21716250 [TBL] [Abstract][Full Text] [Related]
16. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly. Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344 [TBL] [Abstract][Full Text] [Related]
17. [Topiramate: an experience in children with partial epilepsy]. Rocha C; Brucki SM Arq Neuropsiquiatr; 2001 Sep; 59(3-B):768-71. PubMed ID: 11593280 [TBL] [Abstract][Full Text] [Related]